These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11365610)

  • 1. Viral resistance: how it may affect treatment options.
    Biehler GV
    Body Posit; 1998 Jun; 11(6):42-3. PubMed ID: 11365610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance testing debate: does it make the grade?
    Simmons P
    Res Initiat Treat Action; 1999 Oct; 5(4):9-12. PubMed ID: 11366943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Will drug resistance testing prove reliable enough to enhance HIV treatments?
    Murphy MJ
    Fac Notes (New Orleans La); 1998; 10(6):1-3. PubMed ID: 11366139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geno- and phenotypic resistance tests.
    Proj Inf Perspect; 1998 Sep; (25):9-10. PubMed ID: 11365852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 drug resistance assays in clinical management.
    Martinez-Picado J; D'Aquila R
    AIDS Clin Care; 1998 Nov; 10(11):81-5, 87-8. PubMed ID: 11365861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV drug resistance and the other causes of treatment failure.
    Schouten JT
    STEP Perspect; 1997; 9(3):5-8. PubMed ID: 11364937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy.
    Nicastri E; Sarmati L; d'Ettorre G; Palmisano L; Parisi SG; Uccella I; Rianda A; Concia E; Vullo V; Vella S; Andreoni M
    J Med Virol; 2003 Jan; 69(1):1-6. PubMed ID: 12436471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance A-Z.
    Whitson S
    Posit Aware; 1998; 9(6):34-5. PubMed ID: 11366479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypic resistance tests for the management of the patient failing highly active antiretroviral therapy: the resistance pattern in different biological compartments.
    Liuzzi G
    Scand J Infect Dis Suppl; 2003; 106():90-3. PubMed ID: 15000595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV resistance testing proves its value.
    Proj Inf Perspect; 1999 Sep; (28):14. PubMed ID: 11367356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotypic resistance tests for the clinical management of patients with primary HIV infection.
    Narciso P; Lazzarin A
    Scand J Infect Dis Suppl; 2003; 106():66-70. PubMed ID: 15000588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV resistance-testing information on web.
    AIDS Treat News; 2000 Feb; (No 337):6. PubMed ID: 11367209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New questions about therapy. Boston AIDS Writers Group.
    Surviv News (Atlanta Ga); 1998 May; ():19-20. PubMed ID: 11365366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV resistance testing: more questions than answers.
    Mirken B
    AIDS Treat News; 1997 Nov; (No 283):3-5. PubMed ID: 11364909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypic resistance tests for the management of structured therapeutic interruptions after multiple drug failure.
    Montroni M; Monforte AD
    Scand J Infect Dis Suppl; 2003; 106():79-81. PubMed ID: 15000591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Your next nightmare: 28% of new HIV cases may be drug-resistant.
    AIDS Alert; 1999 Dec; 14(12):133-7. PubMed ID: 11366987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug failure and HIV resistance create frustrating scenarios for clinicians.
    Murphy MJ
    Fac Notes (New Orleans La); 1998; 10(5):1-3. PubMed ID: 11365830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.